Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia

BACKGROUND: Treatment of cystic fibrosis-associated lung infections is hampered by the presence of multi-drug resistant pathogens, many of which are also strong biofilm producers. Antimicrobial peptides, essential components of innate immunity in humans and animals, exhibit relevant in vitro antimic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pompilio, Arianna, Crocetta, Valentina, Scocchi, Marco, Pomponio, Stefano, Di Vincenzo, Valentina, Mardirossian, Mario, Gherardi, Giovanni, Fiscarelli, Ersilia, Dicuonzo, Giordano, Gennaro, Renato, Di Bonaventura, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416647/
https://www.ncbi.nlm.nih.gov/pubmed/22823964
http://dx.doi.org/10.1186/1471-2180-12-145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416647/
https://www.ncbi.nlm.nih.gov/pubmed/22823964
http://dx.doi.org/10.1186/1471-2180-12-145

Ejemplares similares